CONMED CORPORATION (CNMD)

Every figure this model derived for CNMD, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 19,806,000 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 37,328,000 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 675,665,000 AssetsCurrent 2026-06-30
current liabilities 455,399,000 LiabilitiesCurrent 2026-06-30
equity 1,041,390,000 StockholdersEquity 2026-06-30
interest expense 31,087,000 InterestExpense 2025-12-31
ocf 170,689,000 NetCashProvidedByUsedInOperatingActivities 2025-12-31
revenue 1,374,724,000 Revenues 2025-12-31
sbc 28,323,000 ShareBasedCompensation 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up CNMD on one particular measure came for.

RatioValue
cash operating margin10.77
current ratio1.48
current ratio reported1.48
dilution pct-0.0
ebit cagr-1.66
ebit yoy-48.77
fcf margin10.98
growth cv0.67
interest cover3.3
net debt ebitda6.65
operating margin7.46
owner earnings margin8.92
revenue growth5.18
revenue growth per share5.18
roic4.41
rule of 4012.65
sbc pct revenue2.06

What to be careful about

What this model itself distrusts about CNMD's figures. Written by the derivation as it ran, not added afterwards.